AAAAAA

   
Results: 1-14 |
Results: 14

Authors: ALTERMAN M BJORSNE M MUHLMAN A CLASSON B KVARNSTROM I DANIELSON H MARKGREN PO NILLROTH U UNGE T HALLBERG A SAMUELSSON B
Citation: M. Alterman et al., DESIGN AND SYNTHESIS OF NEW POTENT C-2-SYMMETRICAL HIV-1 PROTEASE INHIBITORS - USE OF L-MANNARIC ACID AS A PEPTIDOMIMETIC SCAFFOLD, Journal of medicinal chemistry, 41(20), 1998, pp. 3782-3792

Authors: BACKBRO K LOWGREN S OSTERLUND K ATEPO J UNGE T HULTEN J BONHAM NM SCHAAL W KARLEN A HALLBERG A
Citation: K. Backbro et al., UNEXPECTED BINDING MODE OF A CYCLIC SULFAMIDE HIV-1 PROTEASE INHIBITOR, Journal of medicinal chemistry, 40(6), 1997, pp. 898-902

Authors: BJELFMAN C SODERSTROM TG BREKKAN E NORLEN BJ EGEVAD L UNGE T ANDERSSON S RANE A
Citation: C. Bjelfman et al., DIFFERENTIAL GENE-EXPRESSION OF STEROID 5-ALPHA-REDUCTASE-2 IN-CORE NEEDLE BIOPSIES FROM MALIGNANT AND BENIGN PROSTATIC TISSUE, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2210-2214

Authors: LU G UNGE T OWERAATEPO JB SHIH JC EKBLOM J ORELAND L
Citation: G. Lu et al., CHARACTERIZATION AND PARTIAL-PURIFICATION OF HUMAN MONOAMINE OXIDASE-B EXPRESSED IN ESCHERICHIA-COLI, Protein expression and purification, 7(3), 1996, pp. 315-322

Authors: ZHANG H VRANG L BACKBRO K LIND P SAHLBERG C UNGE T OBERG B
Citation: H. Zhang et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WILD-TYPE AND MUTANT REVERSE TRANSCRIPTASES BY THE PHENYL ETHYL THIAZOLYL THIOUREA DERIVATIVES TROVIRDINE AND MSG-127, Antiviral research, 28(4), 1995, pp. 331-342

Authors: AHGREN C BACKRO K BELL FW CANTRELL AS CLEMENS M COLACINO JM DEETER JB ENGELHARDT JA HOGBERG M JASKUNAS SR JOHANSSON NG JORDAN CL KASHER JS KINNICK MD LIND P LOPEZ C MORIN JM MUESING MA NOREEN R OBERG B PAGET CJ PALKOWITZ JA PARRISH CA PRANC P RIPPY MK RYDERGARD C SAHLBERG C SWANSON S TERNANSKY RJ UNGE T VASILEFF RT VRANG L WEST SJ ZHANG H XHOU XX
Citation: C. Ahgren et al., THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1329-1335

Authors: GOOBARLARSSON L LUUKKONEN BGM UNGE T SCHWARTZ S UTTER G STRANDBERG B OBERG B
Citation: L. Goobarlarsson et al., ENHANCEMENT OF HIV-1 PROTEINASE ACTIVITY BY HIV-1 REVERSE-TRANSCRIPTASE, Virology, 206(1), 1995, pp. 387-394

Authors: UNGE T KNIGHT S BHIKHABHAI R LOVGREN S DAUTER Z WILSON K STRANDBERG B
Citation: T. Unge et al., 2.2-ANGSTROM RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1REVERSE-TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS), Structure, 2(10), 1994, pp. 953-961

Authors: UNGE T KNIGHT S BHIKHABHAI R LOVGREN S DAUTER Z WILSON K STRANDBERG B
Citation: T. Unge et al., 2.2-ANGSTROM RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1REVERSE-TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS), Structure, 2(10), 1994, pp. 953-961

Authors: ZHANG H VRANG L BACKBRO K UNGE T NOREEN R OBERG B
Citation: H. Zhang et al., ENZYMATIC-PROPERTIES AND SENSITIVITY TO INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE WITH GLU-138-]ARG AND TYR-188-]HIS MUTATIONS, Antiviral research, 24(1), 1994, pp. 43-57

Authors: BHIKHABHAI R CARLSSON T UNGE T LOVGREN S STRANDBERG B
Citation: R. Bhikhabhai et al., INCREASED YIELD OF HOMOGENEOUS HIV-1 REVERSE-TRANSCRIPTASE (P66 P51) USING A SLOW PURIFICATION APPROACH/, Journal of chromatography, 639(1), 1993, pp. 67-74

Authors: ZHANG H VRANG L UNGE T OBERG B
Citation: H. Zhang et al., CHARACTERIZATION OF HIV REVERSE TRANSCRIPTASES WITH TYR181-]CYS AND LEU100-]IIE MUTATIONS, Antiviral chemistry & chemotherapy, 4(5), 1993, pp. 301-308

Authors: GOOBARLARSSON L BACKBRO K UNGE T BHIKHABHAI R VRANG L ZHANG H ORVELL C STRANDBERG B OBERG B
Citation: L. Goobarlarsson et al., DISRUPTION OF A SALT BRIDGE BETWEEN ASP-488 AND LYS-465 IN HIV-1 REVERSE-TRANSCRIPTASE ALTERS ITS PROTEOLYTIC PROCESSING AND POLYMERASE-ACTIVITY, Virology, 196(2), 1993, pp. 731-738

Authors: BALZARINI J KARLSSON A VANDAMME AM PEREZPEREZ MJ ZHANG H VRANG L OBERG B BACKBRO K UNGE T SANFELIX A VELAZQUEZ S CAMARASA MJ DECLERCQ E
Citation: J. Balzarini et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS SELECTED FOR RESISTANCE AGAINST THE HIV-1-SPECIFIC -OXATHIOLE-2'',2''-DIOXIDE)!-BETA-D-PENTOFURANOSYL (TSAO) NUCLEOSIDE ANALOGS RETAIN SENSITIVITY TO HIV-1-SPECIFIC NONNUCLEOSIDE INHIBITORS, Proceedings of the National Academy of Sciences of the United Statesof America, 90(15), 1993, pp. 6952-6956
Risultati: 1-14 |